Aida Habtezion
Chief Medical Officer and Head of Worldwide Medical & Safety · Stanford Health Care
Credentials: · · · ·
History
- Present
- Present
- Present
- 1999–2002
Gastroenterology
- 1996–1999
Internal Medicine
- 1992–1996
Research
Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation
Cell Host & Microbe · 2020 · Last of 15 authors · Corresponding · 693 citations
Nature Immunology · 2007 · 470 citations
Review · The Lancet · 2020 · 403 citations
21 papers
16 papers
11 papers · 7 as a fellow
9 papers
9 papers
9 papers
8 papers
- SR
8 papers · 1 as a resident
Grants
- 2011–2022
Role of Hemeoxygenase-1 in Experimental Acute Pancreatitis
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.5M · Stanford University
- 2016–2022
Role of Immune Cells in Chronic Pancreatitis
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.2M · Stanford University
- 2015–2021
The Stanford Clinical Center for the Chronic Pancreatitis Research Consortium (CPCRC)
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $2.6M · Stanford University
- 2016–2020
Role and Regulation of Colon Trafficking Novel G-Protein Coupled Receptors
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2M · Stanford University
Clinical trials
- 2020
Principal investigator · Terminated
Stanford University
- 2018
Gastric Acid Suppression and Probiotic Colonization
Principal investigator · Completed · Phase 4
Stanford University
- 2015
Localized Therapeutics for the Treatment of Gastrointestinal Disorders
Principal investigator · Completed
Stanford University